发明名称 METHODS OF INHIBITING CATARACTS AND PRESBYOPIA
摘要 Described herein are methods of inhibiting or reversing the progression of cataract formation or presbyopia in an eye by administering a γ-crystallin charge masking agent. Both presbyopia and cataracts are caused by aggregation of the soluble crystalline lens proteins called the crystallins.
申请公布号 US2016074370(A1) 申请公布日期 2016.03.17
申请号 US201514943471 申请日期 2015.11.17
申请人 UNIVERSITY OF MASSACHUSETTS 发明人 MUTHUKUMAR MURUGAPPAN;MOHR BENJAMIN
分类号 A61K31/4188;A61K31/195;A61K9/00;A61K31/4015 主分类号 A61K31/4188
代理机构 代理人
主权项 1. An ophthalmic composition comprising a bifunctional molecule containing a reactive group covalently linked to a molecular bristle, wherein the reactive group is NH2, a succinimide, a carboxylic acid, isocyanate, an isothiocyanate, a sulfonyl chloride, an aldehyde, a carbodiimide, an acyl azide, an anhydride, a fluorobenzene, a carbonate, an N-hydroxysuccinimide ester, an imidoester, an epoxide or a fluorophenyl ester, and wherein the molecular bristle is a polyethylene glycol having 4 to 200 oxyethylene groups, an alkoxy-polyethylene glycol having 4 to 200 alkoxyethylene groups, an aryloxypolyethylene glycol having 4 to 200 aryloxyethylene groups, poly(2-hydroxypropyl)methacrylamide (HPMA), poly(2-hydroxyethyl)methacrylate (HEMA), a poly(2-oxaziline), poly(m-phosphocholine, poly lysine, or poly glutamic acid, the molecular bristle having a number average molecular weight of 150 to 8000.
地址 BOSTON MA US